Simplifying Healthcare Privacy into 3 Buckets: Consent, Data Sharing, and Policies

A signed BAA is not a compliance strategy. For health marketers evaluating a new tool, “Will the vendor sign a business associate agreement?” matters. But first ask: Which privacy rules apply to our organization, our data, and how we plan to use it? HIPAA obligations depend on whether you’re a covered entity or business associate and whether protected health information (PHI) is involved. A BAA alone doesn’t make a tool—or its use—compliant. And being outside HIPAA doesn’t mean being outside health privacy law. FTC requirements and state consumer health data laws may still apply, including to certain disclosures to advertisers. Before approving your next marketing tool, map the data flow, identify the applicable obligations, and evaluate the controls. Then address the contract. Does your vendor review start with the data? Or the signature?

DPDPA Decoded: A 30-Post LinkedIn Series on Data Protection, Corporate Compliance and Digital Law Post 25 of 30: DPDPA and Digital Marketing How can businesses run effective marketing campaigns while respecting customer privacy? India's Digital Personal Data Protection Act, 2023 (DPDP Act) establishes a framework for responsible processing of digital personal data, with important implications for email marketing, SMS campaigns and personalised advertising. 📩 Key Compliance Areas 🔹 1. Clear Privacy Notices: Explain what personal data is collected and why it is processed. 🔹 2. Consent Management: Where consent is relied upon, ensure it is free, specific, informed, unconditional and unambiguous, with clear affirmative action. 🔹 3. Targeted Advertising: Assess the legal basis for using customer profiles and sharing data with advertising platforms. 🔹 4. Withdrawal of Consent: Provide an accessible withdrawal mechanism and stop relevant consent-based processing as required by law. 🔹 5. Marketing Records: Maintain appropriate records of consent, campaign activity and customer preferences. ⚖️ Why does this matter? For corporate lawyers and marketing compliance teams, these issues are relevant to privacy notices, campaign databases, advertising contracts and data-governance policies. In disputes, consent logs, marketing records, withdrawal timestamps and vendor communications may help establish how personal data was handled. Key takeaway: Effective digital marketing is not just about reaching customers—it is also about transparency, appropriate legal grounds and respecting customer choices. 📚 Legal reference: Sections 5, 6 and 7, Digital Personal Data Protection Act, 2023. Commencement note: Sections 5, 6(1)–(8) and 6(10), and Section 7, are scheduled to commence on 13 May 2027 under the notified phased implementation schedule. Other applicable laws may apply earlier. #DPDPA #DigitalMarketing #DataProtection #CorporateLaw #PrivacyLaw #MarketingCompliance #LegalTech

Marketing moves fast. Compliance reviews shouldn’t slow it down. AdSure helps digital teams spot campaign risk signals and strengthen disclosure copy across FTC, ASA, and GDPR contexts. Start with one campaign and 1–3 assets using the free Campaign Quick Check. Create without risk.

🍪 The cookie jar is running empty. Is your marketing team ready? With major privacy regulations like GDPR and CCPA tightening up and third-party tracking becoming a ghost of marketing’s past, the era of relying on paid ads and external data is coming to a close. 🛑 It’s not just about compliance; it’s a necessary strategic pivot. The solution? A relentless focus on first-party and zero-party data. This is information your customers willingly give you which is far more reliable and valuable than anything a tracker could unearth. You need to start building your own robust customer database now to secure your marketing future and improve customer relationships. Need a concrete plan to collect high-value first-party data without hurting user experience? Here are 3 simple tactics we're using: 🔓 1. Gated Content & Valuable Resources: Offer premium downloads—think industry guides, exclusive webinars, and downloadable templates—in exchange for an email. Make the value proposition undeniable. 🎯 2. Interactive Quizzes & Surveys: Engagement is key. A short, helpful quiz ("What kind of investor are you?") lets you learn specific customer preferences directly from the source while they get immediate value. ⚙️ 3. Preference Centers & Account Creation: Give users control. When they create an account, don't just ask for a password. Ask them to choose what content they want to receive and how frequently. This ensures you only send messages they actually want. The transition may seem daunting, but it's an opportunity to rebuild trust and create a more sustainable marketing ecosystem. Which first-party data tactic has been most successful for you? Let’s share ideas in the comments. 👇 #CookielessFuture #FirstPartyData #ZeroPartyData #DigitalMarketing #DataPrivacy #MarketingStrategy #GDPR #CCPA #FutureOfMarketing #AdTech #MarTech #MarketingTips

📋 HIPAA says your data is de-identified. State privacy law says it's still personal data requiring consent. Who's right? In this episode of our web series PurpleLab's General Counsel Andrew Lucking breaks down a gap that's tripping up healthcare marketers everywhere: privacy regulations and healthcare marketing technology are operating from two different rulebooks. Here's the tension: → HIPAA's expert determination standard asks you to assess reidentification risk based on the specific dataset, recipient, and use case → State privacy laws start from a personal data consent framework (opt-outs, sensitive data labeling) with little technical or operational standardization → The result: two frameworks that don't talk to each other, and a lot of ambiguity in between That ambiguity is exactly where NAI's five-factor analysis comes in, giving companies a way to navigate the space between "de-identified" and "consented" with some rigor. The stakes are real. Advertising use cases were not built with healthcare data in mind, and PurpleLab's whole mission depends on getting that line right. 🎬 Watch the full episode now: #Healthcare #AdTech #DataPrivacy #HIPAA #PrivacyFirst #NAI

𝗣𝗿𝗶𝘃𝗮𝗰𝘆 𝗰𝗼𝗺𝗽𝗹𝗶𝗮𝗻𝗰𝗲 𝘃𝘀 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗴𝗿𝗼𝘄𝘁𝗵? 𝗜𝘁 𝗱𝗼𝗲𝘀𝗻'𝘁 𝗵𝗮𝘃𝗲 𝘁𝗼 𝗯𝗲 𝗮 𝘁𝗿𝗮𝗱𝗲-𝗼𝗳𝗳. A common scenario: a company rolls out a compliant cookie banner, most visitors click "Reject all", and suddenly marketing loses the data it relied on. The first instinct is often to weaken consent. That is the wrong fix. The better question is not "how do we get around consent?" but "how do we get the insight we need without tracking people who said no?" What works in practice: ✅ Separate choices – let users accept "help us improve the website" without accepting ads. Many will. ✅ Anonymous, first-party analytics – count journeys and drop-offs without identifying anyone. ✅ Measure outcomes, not individuals – leads, quotes and sales, plus controlled tests to prove campaign impact. ✅ Contextual targeting – reach the right audience by content and intent, not browsing history. ✅ Ask people directly – surveys and research panels explain the "why" better than tracking ever did. The key is clarity: know what is mandatory, what is flexible, and what the business needs to provide. When compliance and marketing sit at the same table early, campaigns launch on time and trust stays intact. Compliance protects the customer. Smart measurement protects the business. You can have both. #DataPrivacy #Compliance #DataProtection #CookieConsent #MarketingAnalytics #UAE #HealthcareCompliance #ConsumerProtection #ADHICS #GRC #GCC #UAEPDPL #DPDP #GDPR

Healthcare privacy is a state-by-state puzzle. For pharma marketers, the challenge is more complicated than just keeping up with new laws. It’s understanding what legislation, enforcement and case law mean for how audiences are built, activated and measured. That's why we launched Privacy Updates for Marketing Activation (https://lnkd.in/g9YuYkKC). MM+M spoke with our CEO Josh Walsh about the growing complexity and what it means for the industry. Thanks to Bella Czajkowski and the MM+M - Medical Marketing and Media team for continuing the conversation.

The state-by-state fracturing of privacy for healthcare advertising remains one of the defining challenges facing pharma marketers. Historically, access to interpretation and analysis of how the legislation, enforcement, and case law applies to healthcare advertising was a black box, largely dependent on 1:1 conversations between advertiser and vendor. We thought that should change, which is why we released Privacy Updates for Marketing Activation (https://lnkd.in/gb7nA_xQ). This should be an open conversation about how we preserve privacy while also ensure that patients receive critical information that could accelerate improved health outcomes. Great to see MM+M tackle this issue head-on, featuring BranchLab CEO Josh Walsh's perspective.

Healthcare privacy is being defined state by state, but pharma marketers historically have very little access to analysis of what those changes actually mean for advertising. That gap is what led us to create Privacy Updates for Marketing Activation, an open-access resource focused specifically on the implications of legislation, enforcement, and case law for audience strategy, activation, measurement and data use. Great to see Bella Czajkowski and MM+M - Medical Marketing and Media dig into the issue broadly and bring more attention to a challenge that will continue to shape our industry. https://lnkd.in/gyX_uUYQ